Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients
2009 · PLoS ONE · 66 citations
https://doi.org/10.1371/journal.pone.0006745
P
Peter J. Lenting
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
292
Papers
14.2K
Citations
67
h-index
170
i10-index
Peter J. Lenting is an academic researcher from Inserm. The author has contributed to research in topics: Platelet Disorders and Treatments & Blood Coagulation and Thrombosis Mechanisms & Hemophilia Treatment and Research. The author has an h-index of 67, co-authored 249 publications.
ORCID: 0000-0002-7937-3429Papers by this author
worksBinding of Low Density Lipoprotein to Platelet Apolipoprotein E Receptor 2′ Results in Phosphorylation of p38MAPK
2004 · Journal of Biological Chemistry · 53 citations
https://doi.org/10.1074/jbc.m407407200
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
2020 · Nature Communications · 45 citations
https://doi.org/10.1038/s41467-020-17552-3
Antithrombin-lowering in hemophilia: a closer look at fitusiran
2023 · Research and Practice in Thrombosis and Haemostasis · 43 citations
https://doi.org/10.1016/j.rpth.2023.100179
Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity
2016 · Scientific Reports · 38 citations
https://doi.org/10.1038/srep37953
Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors
2020 · EMBO Molecular Medicine · 23 citations
https://doi.org/10.15252/emmm.201911298
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat